GORI, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 33.730
NA - Nord America 32.752
AS - Asia 28.309
SA - Sud America 3.085
AF - Africa 857
OC - Oceania 272
Continente sconosciuto - Info sul continente non disponibili 18
Totale 99.023
Nazione #
US - Stati Uniti d'America 31.230
GB - Regno Unito 8.702
CN - Cina 8.436
SG - Singapore 8.393
IT - Italia 8.025
DE - Germania 6.173
HK - Hong Kong 2.641
VN - Vietnam 2.351
RU - Federazione Russa 2.347
BR - Brasile 2.317
SE - Svezia 1.935
BD - Bangladesh 1.714
FR - Francia 1.446
IN - India 1.276
NL - Olanda 1.160
CA - Canada 1.093
IE - Irlanda 921
FI - Finlandia 772
ID - Indonesia 750
TR - Turchia 540
KR - Corea 535
JP - Giappone 427
UA - Ucraina 382
ES - Italia 323
CI - Costa d'Avorio 281
MX - Messico 253
PL - Polonia 231
AR - Argentina 227
AU - Australia 221
AT - Austria 200
DK - Danimarca 194
CH - Svizzera 186
BE - Belgio 178
CO - Colombia 161
ZA - Sudafrica 156
IQ - Iraq 154
PH - Filippine 128
TW - Taiwan 127
EU - Europa 100
PK - Pakistan 100
CL - Cile 97
TH - Thailandia 85
EC - Ecuador 84
GR - Grecia 77
SA - Arabia Saudita 74
NO - Norvegia 73
RO - Romania 69
MY - Malesia 68
VE - Venezuela 68
IR - Iran 65
AE - Emirati Arabi Uniti 64
MA - Marocco 61
UZ - Uzbekistan 56
PE - Perù 54
EG - Egitto 49
KE - Kenya 48
NZ - Nuova Zelanda 46
CZ - Repubblica Ceca 45
ET - Etiopia 43
NP - Nepal 39
IL - Israele 38
PT - Portogallo 38
TN - Tunisia 37
JO - Giordania 36
NG - Nigeria 33
JM - Giamaica 32
PY - Paraguay 32
DZ - Algeria 31
KZ - Kazakistan 29
HU - Ungheria 27
LT - Lituania 27
AZ - Azerbaigian 24
LU - Lussemburgo 23
UY - Uruguay 23
CR - Costa Rica 22
HR - Croazia 22
GT - Guatemala 21
RS - Serbia 21
SC - Seychelles 21
BO - Bolivia 20
DO - Repubblica Dominicana 19
LB - Libano 19
MD - Moldavia 18
BY - Bielorussia 17
EE - Estonia 17
AL - Albania 16
HN - Honduras 16
KG - Kirghizistan 16
OM - Oman 16
PA - Panama 16
BG - Bulgaria 14
PS - Palestinian Territory 12
AM - Armenia 11
LV - Lettonia 11
GH - Ghana 10
KW - Kuwait 10
MK - Macedonia 10
SN - Senegal 10
SV - El Salvador 10
BB - Barbados 9
Totale 98.885
Città #
Southend 7.563
Singapore 4.638
Ashburn 3.759
Frankfurt am Main 2.425
Dallas 2.356
Hong Kong 2.244
Milan 2.127
Hanover 1.829
San Jose 1.803
Chandler 1.759
Fairfield 1.580
Council Bluffs 1.363
Beijing 1.322
Seattle 1.019
Dublin 893
Los Angeles 880
Princeton 798
Wilmington 789
New York 769
Houston 761
Woodbridge 756
Hefei 749
Ho Chi Minh City 690
Boardman 663
Santa Clara 645
Cambridge 593
Ann Arbor 583
Hanoi 575
Jakarta 551
Rome 523
Lauterbourg 506
Toronto 498
Bengaluru 497
Helsinki 451
Buffalo 417
Moscow 401
Guangzhou 397
Nanjing 377
Shanghai 361
Dearborn 315
Des Moines 292
Abidjan 280
Munich 272
São Paulo 272
The Dalles 268
Tokyo 266
Phoenix 252
Chicago 248
Jacksonville 241
Seoul 235
Redwood City 224
Columbus 221
Nuremberg 219
Istanbul 199
Cangzhou 177
London 159
Berlin 152
Warsaw 149
Redmond 148
Da Nang 138
Naples 138
Atlanta 137
Jinan 136
Turin 136
San Diego 133
Tukwila 133
Mountain View 130
Ottawa 129
Washington 128
Central District 123
Changsha 121
Montreal 121
Shenyang 118
Brussels 114
Silver Spring 114
Lappeenranta 112
Tianjin 112
Shenzhen 107
Haiphong 106
Hangzhou 106
Amsterdam 104
Orem 102
Vienna 94
Boston 92
Bogotá 91
Mumbai 90
Dong Ket 89
Genoa 89
Grafing 89
Nanchang 89
Andover 86
Bologna 86
Serra 85
Madrid 84
Zhengzhou 84
Montréal 81
Paris 81
Sakarya 80
Turku 80
Brooklyn 79
Totale 59.846
Nome #
A second update on mapping the human genetic architecture of COVID-19 1.497
Mapping the human genetic architecture of COVID-19 1.142
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition) 970
Occupational HIV infection in a research laboratory with unknown mode of transmission : a case report 868
Forecasting Hepatitis C liver disease burden on real life data: Does the hidden iceberg matter to reach the elimination goals? 684
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 624
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 580
High-density lipoprotein-cholesterol levels and risk of cancer in HIV-infected subjects Data from the ICONA Foundation Cohort 576
Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients 575
Aumento del peso nelle persone che vivono con infezione da HIV: ritorno al benessere o effetto indesiderato della terapia antiretrovirale? = Weight gain in people living with HIV infection : return to health or adverse event of antiretroviral therapy? 435
The Italian registry of pulmonary non-tuberculous mycobacteria : IRENE: The study protocol 427
Exosomes Recovered From the Plasma of COVID-19 Patients Expose SARS-CoV-2 Spike-Derived Fragments and Contribute to the Adaptive Immune Response 409
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 407
Immunomodulation induced by tucaresol in HIV infection: results of a 16 week pilot Phase I/II trial 392
The impact of SARS-CoV-2 VOCs on clinical outcomes: an overview of reviews 384
Spoligotyping and mycobacterium tuberculosis 373
CD4+ T cell depletion, immune activation and increased production of regulatory T cells in the thymus of HIV-infected individuals 373
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy 365
Incidence, microbiology, and mortality of ventilation-associated pneumonia in a large Italian cohort of critically ill patients: results from the PROSAFE project 364
Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: an observational cohort study 363
SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study 360
Risk of severe non AIDS events is increased among patients unable to increase their CD4 + T-cell counts >200+/μl despite effective HAART 355
Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region : outcome after treatment in recently infected individuals 354
Ripped from the headlines: How can we harness communications to control TB? 354
Fully immunocompetent CD8+ T lymphocytes are present in autologous haematopoietic stem cell transplantation recipients despite an ineffectual T-helper response 353
Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection 352
Evaluation of PCR in detection of Mycobacterium tuberculosis from formalin-fixed, paraffin-embedded tissues : comparison of four amplifiaction assays 346
TLR3 mutations in adult patients with Herpes Simplex virus and Varicella Zoster virus encephalitis 346
Early impairment of gut function and gut flora supporting a role for alteration of gastrointestinal mucosa in human immunodeficiency virus pathogenesis 344
Fatal respiratory infection due to ST308 VIM-1-producing Pseudomonas aeruginosa in a lung transplant recipient : case report and review of the literature 337
Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults : results of the "COPA" pilot randomized trial 336
Switching from efavirenz to rilpivirine improves sleep quality and self-perceived cognition but has no impact on neurocognitive performances : results from a randomized controlled trial 331
Chest X-ray findings in a large cohort of 1117 patients with SARS-CoV-2 infection: a multicenter study during COVID-19 outbreak in Italy 328
Qualitative immune modulation by Interleukin-2 (IL-2) adjuvant therapy in immunological non responder HIV-infected patients 326
Factors affecting antimicrobial resistance in Streptococcus pneumoniae following vaccination introduction 323
Increasing dosages of low-molecular-weight heparin in hospitalized patients with Covid-19 323
A PCR-colorimetric microwell plate hybridization assay for detection of Mycobacterium tuberculosis and M. avium from culture samples and Ziehl-Neelsen-positive smears 321
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 321
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 319
Prevalence of HIV-1 resistant strains in recent seroconverters 314
Evaluation of the effect of protective genetic variants on cART success in HIV-1-infected patients 313
Complement activation and endothelial perturbation parallel COVID-19 severity and activity 312
PCR-hybridization assay for Mycobacterium avium complex: optimization of detection in peripheral blood from humans 311
Guidelines for the use of flow cytometry and cell sorting in immunological studies 311
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: Results from a large multicentre observational prospective cohort (SCOLTA) 310
HIV-DNA decrease during treatment in primary HIV-1 infection with three different drug regimens: Italian Network of Acute HIV Infection (INACTION) clinical trial 309
Response of an Italian reference institute to research challenges regarding a new pandemic: COVID-19 network 305
Rapid Detection and Quantification of Mycobacterium tuberculosis DNA in Paraffinized Samples by Droplet Digital PCR: A Preliminary Study 305
Italian consensus statement on management of HIV-infected individuals with advanced disease naive to antiretroviral therapy 302
Anti-spike antibodies and neutralising antibody activity in people living with HIV vaccinated with COVID-19 mRNA-1273 vaccine: a prospective single-centre cohort study 301
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts : Data from the Icona Foundation Cohort 295
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice 295
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011 291
HIV-infected long-term nonprogressors display a unique correlative pattern between the interleukin-7/interleukin-7 receptor circuit and T-cell homeostasis 290
The NLRP3 Inflammasome Is Upregulated in HIV-Infected Antiretroviral Therapy-Treated Individuals with Defective Immune Recovery 290
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 288
An outbreak of multidrug-resistant tuberculosis involving HIV-infected patients of two hospitals in Milan, Italy 285
Mycobacterium tuberculosis complex genetic diversity : mining the fourth international spoligotyping database (SpolDB4)for classification, population genetics and epidemiology 285
Characteristics and clinical implications of carbapenemase-producing klebsiella pneumoniae colonization and infection, Italy 285
The immunomodulatory nutritional intervention NR100157 reduced CD4 + T-cell decline and immune activation: A 1-year multicenter randomized controlled double-blind trial in HIV-infected persons not receiving antiretroviral therapy (The BITE Study) 284
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 284
Primary HIV infection features colonic damage and neutrophil inflammation yet containment of microbial translocation 278
SARS-CoV-2-related atypical thyroiditis 278
Distinct Metabolic Profile Associated with a Fatal Outcome in COVID-19 Patients during the Early Epidemic in Italy 277
Evidence for type 2 cytokine production and lymphocyte activation in the early phases of HIV-1 infection 275
FoxP3 mRNA Expression in Regulatory T Cells from Patients with Tuberculosis 272
Brain abscess 270
Clinical diagnosis of mycobacterial diseases versus autopsy findings in 350 patients with AIDS 268
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data from the PRESTIGIO Registry 267
Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression 265
Management of Acute Respiratory Failure Due to Community-Acquired Pneumonia: A Systematic Review 262
Duration of quarantine in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a question needing an answer 261
Diagnosis of SARS-CoV-2 in children: accuracy of nasopharyngeal swab compared to nasopharyngeal aspirate 260
Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID 259
Adjuvant treatment of severe varicella pneumonia with intravenous varicella zoster virus-specific immunoglobulins 258
Comparison between Spoligotyping and IS6110 Restriction Fragment Polymorphism in Molecular Genotyping Analysis of Mycobacterium tuberculosis strains 258
Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical Monocytes 258
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study 257
Performance of genotypic tropism testing on proviral DNA in clinical practice : results from the DIVA study group 256
A case of cerebrospinal fluid viral escape on a dual antiretroviral regimen : worth the risk? 256
Exploring early COVID-19 therapies, variants, and viral clearance dynamics: Insights from a high-risk outpatients study 251
Prevalence of extracardiac vascular complications in Abiotrophia spp. and Granulicatella spp. infective endocarditis: Two case reports and a systematic review 251
Human Serum Albumin Is an Essential Component of the Host Defense Mechanism Against Clostridium difficile Intoxication 251
Outbreak of Acute Hepatitis A involving young men in Lombardy region, Italy: Risk factors, clinical and virological characteristics 251
Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy 250
Hospital-Acquired Infections in Critically Ill Patients With COVID-19 250
KIR-HLA genotypes in HIV-infected patients lacking immunological recovery despite effective antiretroviral therapy 248
Influence of Hospitalization upon Diagnosis on the Risk of Tuberculosis Clustering 248
Nested polymerase chain reaction for mycobacterium tuberculosis IS6110 sequence on formalin-fixed paraffin-embedded tissues with granulomatous diseases for rapid diagnosis of tuberculosis 245
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus 244
Skewed T-cell maturation and function in HIV-infected patients failing CD4+ recovery upon long-term virologically suppressive HAART 243
Combination versus sequential monotherapy in chronic HBV infection : a mathematical approach 243
Towards rapid sepsis diagnosis and patients stratification : What's new from microbiology and omics science 243
Autochthonous ST405 NDM-5 producing Escherichia coli causing fatal sepsis in Northern Italy 243
Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of anti-infective therapy (SITA) and the Italian Society of Pulmonology (SIP) 242
Untangling the immunological implications of nadir on CD4+ cell recovery during suppressive highly active antiretroviral therapy 239
COVID-19 multidisciplinary high dependency unit: the Milan model 238
Amplified in situ hybridization with peptide nucleic acid probes for differentiation of Mycobacterium tuberculosis complex and nontuberculous Mycobacterium species on formalin-fixed, paraffin-embedded archival biopsy and autopsy samples 237
Non-AIDS defining cancers in the D:A:D Study-time trends and predictors of survival : a cohort study 237
The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: Results of a 3-year cohort study 235
Totale 34.726
Categoria #
all - tutte 289.006
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 289.006


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021527 0 0 0 0 0 0 0 0 0 0 0 527
2021/20228.843 481 440 536 452 509 427 1.110 1.627 1.052 696 463 1.050
2022/20237.580 980 723 526 782 836 1.284 229 508 789 147 579 197
2023/20247.344 267 410 347 397 1.336 736 603 454 308 523 925 1.038
2024/202516.645 773 1.418 593 1.442 1.069 927 885 1.603 1.199 1.754 1.801 3.181
2025/202638.558 3.231 3.425 4.179 3.248 3.354 2.324 4.672 1.968 3.903 2.800 4.457 997
Totale 102.690